Adverse Prognostic Effect of Methylation in Colorectal Cancer Is Reversed by Microsatellite Instability
- 15 October 2003
- journal article
- gastrointestinal cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (20) , 3729-3736
- https://doi.org/10.1200/jco.2003.03.123
Abstract
Purpose: DNA methylation is an important biologic event in colorectal cancer and in some cases is associated with the development of microsatellite instability (MSI). In this study, we sought to de...Keywords
This publication has 42 references indexed in Scilit:
- Radiotherapy in rectal cancerBritish Medical Bulletin, 2002
- Densely methylated MLH1 promoter correlates with decreased mRNA expression in sporadic colorectal cancersGenes, Chromosomes and Cancer, 2002
- Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ studyBritish Journal of Cancer, 2001
- Correlations of partial and extensive methylation at the p14ARF locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumorsCarcinogenesis: Integrative Cancer Research, 2000
- Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancerThe Lancet, 2000
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000
- Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaProceedings of the National Academy of Sciences, 1998
- c‐erbB‐2 oncoprotein in relation to DNA ploidy and prognosis in colorectal adenocarcinomaAPMIS, 1995
- The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are not short‐term prognostic indicators of survivalInternational Journal of Cancer, 1994
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990